SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Raaj Medisafe India informs about capacity expansion

16 Jan 2024 Evaluate

Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Raaj Medisafe India has informed that the Board of Directors of the Company at its meeting held today, January 16, 2024 at 2.00 pm and concluded at 2.30 pm has approved the proposal to increasing manufacturing capacity. The details as required under Regulation 30 of the LODR Regulations read with SEBI circular dated SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 are enclosed. 

The above information is a part of company’s filings submitted to BSE.

Raaj Medisafe India Share Price

74.01 -1.00 (-1.33%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Lenskart Solutions 512.85
Poly Medicure 1562.55
Laxmi Denta 223.60
Nureca Ltd. 237.70
Hemant Surgical Inds 379.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: